1. Are HIV and Other Chronic Diseases Models Applicable to Viral Hepatitis? Focus on HCV

2. World Epidemiology

3. HCV Epidemiology

5. HCV Subtype Distribution: A Mosaic of Overlapping Sub-Epidemics

6. HIV-1 Subtypes Worldwide

7. U.S. Epidemiology

8. HCV and HIV in the US

9. HIV/HCV in the U.S.: Epidemiological Overlap

10. Prevalence of HCV Ab by Demographic Characteristics 1999-2002 NHANES

13. Relative Importance of Risk Factors for Remote and Recent HCV Infection

15. Testing and Care

16. Current Recs for HCV Testing

19. U.S.: New HIV Infections / Year

20. HCV infection in the U.S.

21. CDC Medical Monitoring Project: HIV Update

22. Virology

23. Viral Genetic Diversity

25. Life Cycle of HIV

26. HCV and HIV Polymerases: Similar Structure and Function

27. HCV and HIV Proteases

28. Virology: Summary

29. Natural History

30. HIV and HCV: Much in Common

31. HCV: Natural History

32. Natural History of HIV Infection

33. Age-Adjusted HCV Mortality: 1995-2005

35. Treatment

36. Assessing Virologic Response in HCV Therapy

37. HIV Therapy:

39. HCV Protease Inhibitors

40. Independent Predictors of Sustained Virologic Response (Logistic Regression)

41. HIV Drug Approval:

42. ART:

43. HIV Drug Approval:

44. HIV Drug-Resistance Testing

45. HIV Cure (N=1)

46. HCV and HIV: Treatment Issues

47. HCV + HIV: Healthcare Team

48. HCV and HIV: Summary

49. Acknowledgments